Company Filing History:
Years Active: 2009-2018
Title: Alexandr Gabibovich Gabibov: Innovator in Medical Treatments
Introduction
Alexandr Gabibovich Gabibov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of medical treatments, particularly in the area of autoimmune diseases. With a total of 2 patents, his work focuses on innovative solutions for complex health issues.
Latest Patents
Gabibov's latest patents include a composition for the treatment of multiple sclerosis, which involves novel oligopeptides. These oligopeptides are homologous in amino acid sequence to selected parts of the human myelin basic protein (MBP). They are designed to ameliorate the progression of multiple sclerosis by binding to and inactivating epitope-specific anti-MBP catalytic autoantibodies (ESAMBPCAA). This innovative approach aims to halt the degradation of MBP during the progression of the disease. Another significant patent is a method for producing catalytic antibodies and antigens for immunization. This method utilizes animals with spontaneous and induced autoimmune pathologies to create a catalytic vaccine that exhibits adhesive properties to antigens while also performing a destructive function, thereby suspending disease progression.
Career Highlights
Throughout his career, Gabibov has worked with notable companies such as FDS Pharma and Lifebio Laboratories LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Gabibov has collaborated with several professionals in his field, including Natalya Alexandrovna Ponomarenko and Alexandr Vladimirovich Kolesnikov. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Alexandr Gabibovich Gabibov is a dedicated inventor whose work in medical treatments showcases his commitment to addressing complex health challenges. His innovative patents and collaborations highlight his significant contributions to the field of medicine.